Viewing Study NCT00002751



Ignite Creation Date: 2024-05-05 @ 11:21 AM
Last Modification Date: 2024-10-26 @ 9:03 AM
Study NCT ID: NCT00002751
Status: COMPLETED
Last Update Posted: 2013-06-20
First Post: 1999-11-01

Brief Title: Monoclonal Antibody Therapy in Treating Patients With Brain Metastases
Sponsor: Duke University
Organization: Duke University

Study Overview

Official Title: PROTOCOL FOR A PHASE I STUDY OF INTRATHECAL MONOCLONAL ANTIBODY FRAGMENT 131I Me1-14 Fab2 IN PATIENTS WITH NEOPLASMS METASTATIC TO THE LEPTOMENINGES
Status: COMPLETED
Status Verified Date: 2009-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: RATIONALE Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells

PURPOSE Phase III trial to study the effectiveness of monoclonal antibody therapy in treating patients who have brain metastases
Detailed Description: OBJECTIVES I Determine the toxicity and maximum tolerated dose of 131-iodine-labeled monoclonal antibody fragment Me1-14 Fab2 administered intrathecally in patients with neoplasms metastatic to the leptomeninges II Identify objective therapeutic responses to this treatment

OUTLINE Radioimmunotherapy Iodine-131-Labeled Monoclonal Antibody Fragment Me1-14 Fab2 131I-Me1-14 Fab2

PROJECTED ACCRUAL Three to 6 patients will be treated at each dose studied

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
CDR0000064687 OTHER NCI None
DUMC-1193-006R11 None None None
DUMC-1017-96-7R7 None None None
DUMC-1100-97-7R8 None None None
DUMC-1159-98-7R9 None None None
DUMC-1229-99-7R10 None None None
DUMC-657897 None None None
DUMC-997-95-7R6 None None None
NCI-V90-0052 None None None
NCI-H96-0010 None None None